Possible association of β-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia

Masashi Ikeda, N. Ozaki, T. Suzuki, Tsuyoshi Kitajima, Y. Yamanouchi, Y. Kinoshita, T. Kishi, Y. Sekine, M. Iyo, M. Harano, T. Komiyama, M. Yamada, I. Sora, H. Ujike, T. Inada, Nakao Iwata

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Recent investigations suggest that the AKT/glycogen synthase kinase 3 (GSK3) signaling cascade may be associated with the pathophysiology of schizophrenia and methamphetamine (METH) use disorder. One important molecule related to this cascade is β-arrestin 2 (ARRB2). We therefore conducted a genetic case-control association analysis of the gene for ARRB2 with schizophrenia and METH use disorder in a Japanese population (547 people with schizophrenia, 177 with METH use disorder and 546 controls). A possible association of 'tag single nucleotide polymorphisms (SNPs)' was found in METH use disorder (rs1045280: Pgenotype = 0.0118, Pallele = 0.00351; rs2036657: Pallele = 0.0431; rs4790694: Pgenotype = 0.0167, Pallele = 0.0202), but no association was found with schizophrenia. We also evaluated the gene-gene interactions among ARRB2, AKT1, and GSK3B, which we previously reported for each of these diseases. However, no interaction was seen in our samples. This is the first association analysis of ARRB2, and our results indicate that ARRB2 may play a role in the pathophysiology of METH use disorder.

Original languageEnglish
Pages (from-to)107-112
Number of pages6
JournalGenes, Brain and Behavior
Volume6
Issue number1
DOIs
Publication statusPublished - 01-02-2007

Fingerprint

Methamphetamine
Schizophrenia
Genes
Glycogen Synthase Kinase 3
Single Nucleotide Polymorphism
beta-Arrestin 1
Population

All Science Journal Classification (ASJC) codes

  • Genetics
  • Neurology
  • Behavioral Neuroscience

Cite this

Ikeda, Masashi ; Ozaki, N. ; Suzuki, T. ; Kitajima, Tsuyoshi ; Yamanouchi, Y. ; Kinoshita, Y. ; Kishi, T. ; Sekine, Y. ; Iyo, M. ; Harano, M. ; Komiyama, T. ; Yamada, M. ; Sora, I. ; Ujike, H. ; Inada, T. ; Iwata, Nakao. / Possible association of β-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia. In: Genes, Brain and Behavior. 2007 ; Vol. 6, No. 1. pp. 107-112.
@article{78fdf0a0a7bb4c9aa38f9308df8b9956,
title = "Possible association of β-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia",
abstract = "Recent investigations suggest that the AKT/glycogen synthase kinase 3 (GSK3) signaling cascade may be associated with the pathophysiology of schizophrenia and methamphetamine (METH) use disorder. One important molecule related to this cascade is β-arrestin 2 (ARRB2). We therefore conducted a genetic case-control association analysis of the gene for ARRB2 with schizophrenia and METH use disorder in a Japanese population (547 people with schizophrenia, 177 with METH use disorder and 546 controls). A possible association of 'tag single nucleotide polymorphisms (SNPs)' was found in METH use disorder (rs1045280: Pgenotype = 0.0118, Pallele = 0.00351; rs2036657: Pallele = 0.0431; rs4790694: Pgenotype = 0.0167, Pallele = 0.0202), but no association was found with schizophrenia. We also evaluated the gene-gene interactions among ARRB2, AKT1, and GSK3B, which we previously reported for each of these diseases. However, no interaction was seen in our samples. This is the first association analysis of ARRB2, and our results indicate that ARRB2 may play a role in the pathophysiology of METH use disorder.",
author = "Masashi Ikeda and N. Ozaki and T. Suzuki and Tsuyoshi Kitajima and Y. Yamanouchi and Y. Kinoshita and T. Kishi and Y. Sekine and M. Iyo and M. Harano and T. Komiyama and M. Yamada and I. Sora and H. Ujike and T. Inada and Nakao Iwata",
year = "2007",
month = "2",
day = "1",
doi = "10.1111/j.1601-183X.2006.00237.x",
language = "English",
volume = "6",
pages = "107--112",
journal = "Genes, Brain and Behavior",
issn = "1601-1848",
publisher = "Wiley-Blackwell",
number = "1",

}

Ikeda, M, Ozaki, N, Suzuki, T, Kitajima, T, Yamanouchi, Y, Kinoshita, Y, Kishi, T, Sekine, Y, Iyo, M, Harano, M, Komiyama, T, Yamada, M, Sora, I, Ujike, H, Inada, T & Iwata, N 2007, 'Possible association of β-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia', Genes, Brain and Behavior, vol. 6, no. 1, pp. 107-112. https://doi.org/10.1111/j.1601-183X.2006.00237.x

Possible association of β-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia. / Ikeda, Masashi; Ozaki, N.; Suzuki, T.; Kitajima, Tsuyoshi; Yamanouchi, Y.; Kinoshita, Y.; Kishi, T.; Sekine, Y.; Iyo, M.; Harano, M.; Komiyama, T.; Yamada, M.; Sora, I.; Ujike, H.; Inada, T.; Iwata, Nakao.

In: Genes, Brain and Behavior, Vol. 6, No. 1, 01.02.2007, p. 107-112.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Possible association of β-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia

AU - Ikeda, Masashi

AU - Ozaki, N.

AU - Suzuki, T.

AU - Kitajima, Tsuyoshi

AU - Yamanouchi, Y.

AU - Kinoshita, Y.

AU - Kishi, T.

AU - Sekine, Y.

AU - Iyo, M.

AU - Harano, M.

AU - Komiyama, T.

AU - Yamada, M.

AU - Sora, I.

AU - Ujike, H.

AU - Inada, T.

AU - Iwata, Nakao

PY - 2007/2/1

Y1 - 2007/2/1

N2 - Recent investigations suggest that the AKT/glycogen synthase kinase 3 (GSK3) signaling cascade may be associated with the pathophysiology of schizophrenia and methamphetamine (METH) use disorder. One important molecule related to this cascade is β-arrestin 2 (ARRB2). We therefore conducted a genetic case-control association analysis of the gene for ARRB2 with schizophrenia and METH use disorder in a Japanese population (547 people with schizophrenia, 177 with METH use disorder and 546 controls). A possible association of 'tag single nucleotide polymorphisms (SNPs)' was found in METH use disorder (rs1045280: Pgenotype = 0.0118, Pallele = 0.00351; rs2036657: Pallele = 0.0431; rs4790694: Pgenotype = 0.0167, Pallele = 0.0202), but no association was found with schizophrenia. We also evaluated the gene-gene interactions among ARRB2, AKT1, and GSK3B, which we previously reported for each of these diseases. However, no interaction was seen in our samples. This is the first association analysis of ARRB2, and our results indicate that ARRB2 may play a role in the pathophysiology of METH use disorder.

AB - Recent investigations suggest that the AKT/glycogen synthase kinase 3 (GSK3) signaling cascade may be associated with the pathophysiology of schizophrenia and methamphetamine (METH) use disorder. One important molecule related to this cascade is β-arrestin 2 (ARRB2). We therefore conducted a genetic case-control association analysis of the gene for ARRB2 with schizophrenia and METH use disorder in a Japanese population (547 people with schizophrenia, 177 with METH use disorder and 546 controls). A possible association of 'tag single nucleotide polymorphisms (SNPs)' was found in METH use disorder (rs1045280: Pgenotype = 0.0118, Pallele = 0.00351; rs2036657: Pallele = 0.0431; rs4790694: Pgenotype = 0.0167, Pallele = 0.0202), but no association was found with schizophrenia. We also evaluated the gene-gene interactions among ARRB2, AKT1, and GSK3B, which we previously reported for each of these diseases. However, no interaction was seen in our samples. This is the first association analysis of ARRB2, and our results indicate that ARRB2 may play a role in the pathophysiology of METH use disorder.

UR - http://www.scopus.com/inward/record.url?scp=33846122964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846122964&partnerID=8YFLogxK

U2 - 10.1111/j.1601-183X.2006.00237.x

DO - 10.1111/j.1601-183X.2006.00237.x

M3 - Article

C2 - 17233643

AN - SCOPUS:33846122964

VL - 6

SP - 107

EP - 112

JO - Genes, Brain and Behavior

JF - Genes, Brain and Behavior

SN - 1601-1848

IS - 1

ER -